Full Body MRI Cost in 2026: Prenuvo vs. Ezra and the Honest Case for Physician Guidance

What you're paying for

What a Preventive Whole-Body MRI Actually Includes

A preventive full-body MRI is a non-contrast scan of most of the body — brain, neck, chest, abdomen, pelvis, and major joints — performed without symptoms to screen for asymptomatic disease. It uses no ionizing radiation, no IV contrast in the standard preventive protocols, and takes 30–60 minutes depending on the platform.

Reports typically cover the brain, head and neck, thyroid, lungs, heart and great vessels, liver, kidneys, pancreas, spleen, adrenals, GI tract, reproductive organs, prostate or uterus/ovaries, lymph nodes, musculoskeletal structures, and the spine. Most providers use AI to flag suspicious findings, with radiologist sign-off.

Provider pricing

Prenuvo, Ezra, and Other Providers in 2026

Prenuvo positions itself at the premium end — a single head-to-ankle scan at roughly $2,499 in most markets, with annual membership bundles for follow-up scans and physician consultation that run higher. The Prenuvo protocol is longer (about 60 minutes) and produces the most extensive standard preventive report in the category.

Ezra — acquired by Function Health in 2024 — has restructured around a tiered model. The Ezra Flash entry-tier scan starts under $1,000 with shorter scan times and a more targeted protocol; the Full and Plus tiers approach Prenuvo on scope and pricing. Bundling with Function Health membership shifts the value proposition toward an integrated biomarker-plus-imaging program rather than a standalone scan.

Hospital-based screening MRI is a smaller market — usually run through academic preventive medicine programs, often $1,500–$3,500 cash, often requiring a physician order, with the strongest radiologist interpretation but the least patient-friendly logistics.

Coverage

Does Insurance Cover It?

Generally no. Preventive whole-body MRI in asymptomatic adults is not covered by commercial insurance, Medicare, or Medicaid. The exceptions are narrow: surveillance protocols in patients with specific high-risk genetic syndromes (Li-Fraumeni, certain BRCA contexts, von Hippel-Lindau) where evidence-based screening is established.

HSA and FSA funds can typically be used for the scan when ordered or recommended by a physician, depending on plan rules. Concierge and longevity medicine memberships that bundle the scan rarely affect insurance coverage status.

The honest case

What Major Radiology Bodies Say — and Why It Matters

The American College of Radiology does not endorse whole-body MRI as a routine screening tool for average-risk asymptomatic adults. The concern is not that the scan is dangerous — it does not use ionizing radiation — but that it produces a substantial rate of incidental findings.

Most incidental findings are benign (cysts, hemangiomas, small nodules, age-related changes). A meaningful share of them trigger downstream workups: additional imaging with contrast and radiation, biopsies, anxiety, and occasional procedural complications. For an average-risk patient, the math of catching one early cancer versus chasing many benign findings has not been resolved in the literature.

This is not an argument against the scan. It is an argument for physician-guided candidacy. A 52-year-old with a family history of pancreatic cancer, elevated ApoB, and chronic inflammation is a different candidate than a 28-year-old with no risk factors.

Who benefits

Who Actually Benefits From a Preventive Whole-Body MRI

Reasonable candidates, in physician judgment:

• ·Patients with a strong family history of cancer or cardiovascular disease without genetic syndrome qualification for surveillance imaging.
• ·Patients with multiple metabolic risk factors and rising cardiometabolic biomarkers.
• ·Patients with vague systemic symptoms not yet explained by targeted workup.
• ·Executive-physical and longevity-program patients using imaging as one data point among many.
• ·Patients with high anxiety about occult disease, when the physician can manage findings appropriately.

Less compelling candidates: young, asymptomatic, low-risk patients with no family history, where the incidental-finding rate likely outweighs the screening yield.

Companion tests

What to Pair It With

A whole-body MRI is most useful as part of a structured executive or longevity physical, not as a standalone scan. Companion tests that add information the MRI does not provide:

• ·Coronary artery calcium score (CAC) — non-contrast CT, $100–$500, the strongest single imaging predictor of future cardiac events.
• ·Comprehensive cardiometabolic biomarkers: ApoB, Lp(a), advanced lipid panel, HbA1c, fasting insulin, hs-CRP.
• ·DEXA scan for bone density and body composition.
• ·Multi-cancer early detection blood test (Galleri and similar) where appropriate.

A physician-built program selects from these based on the patient's individual risk profile rather than running every test on every patient.